Product correctly added to cart.

discount label
(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one
View 3D

Biosynth logo

(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one

CAS: 1622291-66-0

Ref. 3D-XPC29166

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Wednesday 18 Dec 2024

Product Information

Name:
(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one
Description:

(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one is a drug that has been found to be reactive in nonhuman primates. This drug stimulates the immune system by activating T cells and B cells. It has also been shown to activate metabotropic glutamate receptors in primates. This drug can be used as a screening tool for the identification of new drugs with similar properties and may be a potential treatment for skin allergies in humans.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
329.4 g/mol
Formula:
C18H23N3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-XPC29166 (6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".